Vlado Perkovic's Publications

About Vlado Perkovic's Publications

Board Member
  • MBBS,
  • PhD,
  • FASN,
  • FRACP

  • Redefining Blood-Pressure Targets - SPRINT Starts the Marathon

    New England Journal of Medicine Date published:

  • Renal effects of canagliflozin in type 2 diabetes mellitus

    Current Medical Research and Opinion Date published:

  • International trials in middle-income countries: different local scenarios require different ethical approaches

    Journal of the Royal Society of Medicine Date published:

  • Relationship between Serum Uric Acid Levels and Chronic Kidney Disease in a Japanese Cohort with Normal or Mildly Reduced Kidney Function

    PLOS ONE Date published:

  • Predictors of Atrasentan-Associated Fluid Retention and Change in Albuminuria in Patients with Diabetic Nephropathy

    Clinical Journal of the American Society of Nephrology Date published:

  • Assessing the Validity of Surrogate Outcomes for ESRD

    Journal of the American Society of Nephrology Date published:

  • First Light After the Long Night: A Follow-up Report of the Randomized FHN Nocturnal Trial

    American Journal of Kidney Diseases Date published:

  • Kidney Disease End Points in a Pooled Analysis of Individual Patient-Level Data From a Large Clinical Trials Program of the Dipeptidyl Peptidase 4 Inhibitor Linagliptin in Type 2 Diabetes

    American Journal of Kidney Diseases Date published:

  • Lowering cholesterol in chronic kidney disease: is it safe and effective?

    European Heart Journal Date published:

  • Relationship Between Levels of Advanced Glycation End Products and Their Soluble Receptor and Adverse Outcomes in Adults With Type 2 Diabetes

    Diabetes Care Date published:

  • Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease

    Cochrane Database of Systematic Reviews Date published:

  • Research Priorities in CKD: Report of a National Workshop Conducted in Australia

    American Journal of Kidney Diseases Date published:

  • Prediction of the effect of atrasentan on renal and heart failure outcomes based on short-term changes in multiple risk markers

    European Journal of Preventive Cardiology Date published:

  • Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA-T2D ™ trial

    Diabetes and Vascular Disease Research Date published:

  • Erratum. The Relative and Combined Ability of High-Sensitivity Cardiac Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide to Predict Cardiovascular Events and Death in Patients With Type 2 Diabetes. Diabetes Care 2014;37:295-303

    Diabetes Care Date published:

  • Efficacy and Safety of Canagliflozin Used in Conjunction with Sulfonylurea in Patients with Type 2 Diabetes Mellitus: A Randomized, Controlled Trial

    Diabetes Therapy Date published: